Ken Griffin started to build up the position in Imago BioSciences in Q3 2021 and continued to invest until Q2 2022. Since then they sold 2.52 Million shares. The investor completely sold their stake between Q3 2022 and Q1 2023.
Avg closing price
Price range
Sold -97.3 Thousand shares
Q1 2023
Avg closing price
$35.99
Price range
$35.97
-
$36.01
Sold 96.1% shares (-2.37 Million shares)
Q4 2022
Avg closing price
$25.00
Price range
$15.03
-
$35.96
Sold 2.1% shares (-52.3 Thousand shares)
Q3 2022
Avg closing price
$16.22
Price range
$14.15
-
$19.50
Increased shares by 0.7% (+18.6 Thousand shares)
Q2 2022
Avg closing price
$15.87
Price range
$11.81
-
$20.92
Increased shares by 1.9% (+45.5 Thousand shares)
Q1 2022
Avg closing price
$20.75
Price range
$16.97
-
$25.00
Increased shares by 20.1% (+410 Thousand shares)
Q4 2021